Comparison of the effect of simvastatin, spironolactone and L-arginine on endothelial function of aorta in hereditary hypertriglyceridemic rats

Physiological Research

Volumn 56, Issue SUPPL. 2, 2007, Pages

  Török, Jozef ^a   L'uptak I ^b   Matuskova J ^b   Pechanova O ^a   Zicha, J ^c   Kunes J ^c   Simko F ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Bratislava   (Slovakia)

^c INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Blood pressure; Contraction; L arginine; Relaxation; Simvastatin; Spironolactone; Thoracic aorta

Indexed keywords

ACETYLCHOLINE; ALDOSTERONE ANTAGONIST; ARGININE; ENOS PROTEIN, RAT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NORADRENALIN; SIMVASTATIN; SPIRONOLACTONE; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL; AORTA; ARTICLE; BLOOD PRESSURE; COMPARATIVE STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; GENETICS; HYPERTRIGLYCERIDEMIA; MALE; METABOLISM; PATHOPHYSIOLOGY; RAT; TIME; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION; WISTAR RAT;

ACETYLCHOLINE; ALDOSTERONE ANTAGONISTS; ANIMALS; AORTA; ARGININE; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTRIGLYCERIDEMIA; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NOREPINEPHRINE; RATS; RATS, WISTAR; SIMVASTATIN; SPIRONOLACTONE; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 38549179477     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. ALVAREZ DE SOTOMAYOR M, HERRERA MD, MARHUENDA E, ANDRIANTSITOHAINA R: Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat. Br J Pharmacol 131: 1179-1187, 2000.
2. BANOS G, MEDINA-CAMPOS ON, MALDONADO PD, ZAMORA J, PEREZ I, PAVON N, PEDRAZA-CHAVERRI J: Antioxidant enzymes in hypertensive and hypertrigyceridemic rats: effect of gender. Clin Exp Hypertens 27: 45-57, 2005.
3. BARTUŠ M, LOMNICKÁ M, LORKOWSKÁ B, FRANCZYK M, KOSTOGRYS RB, PISULEWSKI PM, CHLOPICKI S: Hypertriglyceridemia but not hypercholesterolemia induces endothelial dysfunction in the rat. Pharmacol Rep 57 (Suppl): 127-137, 2005.
4. BATES K, RUGGEROLI CE, GOLDMAN S, GABALLA MA: Simvastatin restores endothelial NO-mediated vasorelaxation in large arteries after myocardial infarction. Am J Physiol 283: H768-H775, 2002.
5. ČAČÁNYIOVÁ S, CEBOVÁ M, KUNEŠ J, KRISTEK F: Comparison of vascular function and structure of iliac artery in spontaneously hypertensive and hereditary hypertriglyceridemic rats. Physiol Res 55 (Suppl 1): S73-S79, 2006.
6. IKEDA U, KANBE T, NAKAYAMA I, KAWAHARA Y, YOKOYAMA M, SHIMADA K: Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 beta. Eur J Pharmacol 290: 69-73, 1995.
7. KATAKAM PV, UJHELYI MR, HOENIG ME, MILLER AW: Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Am J Physiol 275: R788-R792, 1998.
8. KAZDOVÁ L, DIVIŠOVÁ J, HUBOVÁ H: Effect of nitric oxide synthase inhibition on glucose utilization in an experimental model of insulin resistance. Physiol Res 50: P37, 2001.
9. KLIMEŠ I, VRÁNA A, KUNEŠ J, ŠEBÖ KOVÁ E, DOBEŠOVÁ Z, ŠTOLBA P, ZICHA J: Hereditary hypertriglyceridemic rat: a new animal model of metabolic alterations in hypertension. Blood Pressure 4: 137-142, 1995.
10. KLIMEŠ I, ZICHA J, KUNEŠ J, ŠEBOKOVÁ E: Hypertriglyceridemia, insulin resistance and hypertension in rats: are they related? Endocr Regul 31: 103-119, 1997.
11. KRISTEK F: Long-term administration of L-arginine did not influence blood pressure, heart rate, cardiac hypertrophy or arterial thickness of spontaneously hypertensive rats. Exp Physiol 83: 595-603, 1998.
12. KUCHARSKÁ J, GVOZDJÁKOVÁ A, ŠIMKO F: Simvastatin decresed coenzyme Q in the left ventricle and skeletal muscle but not in the brain and kidney in L-NAME-induced hypertension. Physiol Res 56 (Suppl 2): S49-S54, 2007.
13. KUSTERER K, POHL T, FORTMEYER HP, MARZ W, SCHARNAGL H, OLDENBURGR A, ANGERMULLER S, FLEMING I, USADEL KH, BUSSE R: Chronic selective hypertriglyceridemia impairs endothelium dependent vasodilation in rats. Cardiovasc Res 42: 783-793, 1999.
14. LIAO JK, LAUFS U: Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45: 89-118, 2005.
15. MORITOKI H, UEDA H, YAMAMOTO T, HISAYAMA T, TAKEUCHI S: L-arginine induces relaxation of rat aorta possibly through non-endothelial nitric oxide formation. Br J Pharmacol 102: 841-846, 1991.
16. NAKAKI T, HISHIKAWA K, SUZUKI H, SARUTA T, KATO R: L-arginine induced hypotension. Lancet 336: 696, 1990.
17. PECHÁŇOVÁ O, MATÚŠKOVÁ J, CAPÍKOVÁ D, JENDEKOVÁ L, PAULIS ?, ŠIMKO F: Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats. Kidney Int 70: 170-176, 2006.
18. PEREZ-GUERRERO C, MARQUEZ-MARTIN A, HERRERA MD, MARHUENDA E, ALVAREZ DE SOTOMAYOR M: Regulation of vascular tone from spontaneously hypertensive rats by the HMG-CoA reductase inhibitor, simvastatin. Pharmacology 74: 209-215, 2005.
19. QUASCHNING T, RUSCHITZKA F, SHAW S, LÜSCHER TF: Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension. Hypertension 37: 801-805, 2001.
20. ROMERO MJ, PLATT DH, CALDWELL RB, CALDWELL RW: Therapeutic use of citrulline in cardiovascular disease. Cardiovasc Drug Rev 24: 275-290, 2006.
21. SCHAFER A, FRACCAROLLO D, HILDEMANN SK, TAS P, ERTL G, BAUERSACHS J: Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction. Cardiovascular Res 58: 655-662, 2003.
22. ŠIMKO F: Is NO the king? Pathophysiological benefit with uncertain clinical impact. Physiol Res 56 (Suppl 2): S1-S6, 2007a.
23. ŠIMKO F: Statin - a perspective for left ventricular hypertrophy treatment. Eur J Clin Invest 37: 681-691, 2007b.
24. ŠIMKO F, LUPTÁK I, MATÚŠKOVÁ J, BABÁL P, PECHÁŇOVÁ O, BERNÁTOVÁ I, HULÍN I: Heart remodeling in the hereditary hypertriglyceridemic (hHTG) rat: effect of captopril and nitric oxide deficiency. Ann NY Acad Sci 967: 454-462, 2002.
25. ŠIMKO F, LUPTÁK I, MATÚŠKOVÁ J, KRAJČÍROVIČOVÁ K, SUMBALOVÁ Z, KUCHARSKÁ J, GVOZDJAKOVÁ A, ŠIMKO J, BABÁL P, PECHÁŇOVA O, BERNATOVÁ I: L-arginine fails to protect against myocardial remodeling in L-NAME-induced hypertension. Eur J Clin Invest 35: 362-368, 2005.
26. STIER CT, SIM GJ, LEVINE S: Dietary arginine fails to protect against cerebrovascular damage in stroke-prone hypertensive rats. Brain Res 549: 354-356, 1991.
27. ŠTOLBA P, DOBEŠOVÁ Z, HUŠEK P, OPLTOVÁ H, ZICHA J, VRÁNA A, KUNEŠ J: The hypertriglyceridemic rat as a genetic model of hypertension and diabetes. Life Sci 51: 733-740, 1992.
28. TAKEMOTO M, NODE K, NAKAGAMI H, LIAO Y, GRIMM M, TAKEMOTO Y, KITAKAZE M, LIAO JK: Statitns as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 108: 1429-37, 2001.
29. TÖRÖK J, HOLÉCYOVÁ A, KYSELÁ S, BERNÁTOVA I, PECHÁŇOVÁ O: Changes in reactivity OF pulmonary and systemic arteries in chronic NO-deficient hypertension. (in Slovak) Cardiology 7: 30-36, 1998.
30. TÖRÖK J, BABÁL P, MATÚŠKOVÁ J, LUPTÁK I, KLIMEŠ I, ŠIMKO F: Impaired endothelial function of thoracic aorta in hereditary hypertriglyceridemic rats. Ann N Y Acad Sci 967: 469-475, 2002.
31. TÖRÖK J, KRISTEK F, GEROVÁ M, KUNEŠ J, DOBEŠOVÁ Z: Endothelial function of conduit artery in newborn rats with hereditary hypertriglyceridemia. Physiol Res 52: 52P, 2003.
32. TÖRÖK J, KOPRDOVÁ R, CEBOVÁ M, KUNEŠ J, KRISTEK F: Functional and structural pattern of arterial responses in hereditary hypertriglyceridemic and spontaneously hypertensive rats. Physiol Res 55 (Suppl 1): S65-S71, 2006.
33. VAUGHAN CJ, MURPHY MB, BUCKLEY BM: Statins do more than just lower cholesterol. Lancet 348: 1079-1082, 1996.
34. VRÁNA A, KAZDOVÁ L: The hereditary hypertriglyceridemic nonobese rat: an experimental model of human hypertriglyceridemia. Transpl Proc 22: 2579, 1990.
35. WAGNER AH, KOHLER T, RUCKSCHLOSS U, JUST I, HECKER M: Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Biol 20: 61-69, 2000.
36. ZICHA J, PECHÁŇOVÁ O, ČAČÁ NYIOVÁ S, CEBOVÁ M, KRISTEK F, TÖRÖK J, ŠIMKO F, DOBEŠOVÁ Z, KUNEŠ J: Hereditary hypertriglyceridemic rat: a suitable model of cardiovascular disease and metabolic syndrome? Physiol Res 55 (Suppl 1): S49-S63, 2006.